img

Global CRISPR And CRISPR-Associated Genes Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CRISPR And CRISPR-Associated Genes Market Research Report 2024

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
According to MRAResearch’s new survey, global CRISPR And CRISPR-Associated Genes market is projected to reach US$ 1770.3 million in 2033, increasing from US$ 1384.4 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CRISPR And CRISPR-Associated Genes market research.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CRISPR And CRISPR-Associated Genes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Segment by Application


Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CRISPR And CRISPR-Associated Genes report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 GRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR And CRISPR-Associated Genes Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR And CRISPR-Associated Genes Market Perspective (2018-2033)
2.2 CRISPR And CRISPR-Associated Genes Growth Trends by Region
2.2.1 Global CRISPR And CRISPR-Associated Genes Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 CRISPR And CRISPR-Associated Genes Historic Market Size by Region (2018-2023)
2.2.3 CRISPR And CRISPR-Associated Genes Forecasted Market Size by Region (2024-2033)
2.3 CRISPR And CRISPR-Associated Genes Market Dynamics
2.3.1 CRISPR And CRISPR-Associated Genes Industry Trends
2.3.2 CRISPR And CRISPR-Associated Genes Market Drivers
2.3.3 CRISPR And CRISPR-Associated Genes Market Challenges
2.3.4 CRISPR And CRISPR-Associated Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue
3.1.1 Global Top CRISPR And CRISPR-Associated Genes Players by Revenue (2018-2023)
3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR And CRISPR-Associated Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR And CRISPR-Associated Genes Revenue
3.4 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio
3.4.1 Global CRISPR And CRISPR-Associated Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated Genes Revenue in 2022
3.5 CRISPR And CRISPR-Associated Genes Key Players Head office and Area Served
3.6 Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service
3.7 Date of Enter into CRISPR And CRISPR-Associated Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR And CRISPR-Associated Genes Breakdown Data by Type
4.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Type (2018-2023)
4.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2024-2033)
5 CRISPR And CRISPR-Associated Genes Breakdown Data by Application
5.1 Global CRISPR And CRISPR-Associated Genes Historic Market Size by Application (2018-2023)
5.2 Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
6.2 North America CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
6.4 North America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
7.2 Europe CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
7.4 Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
8.2 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023)
8.4 Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
9.2 Latin America CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
9.4 Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size (2018-2033)
10.2 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023)
10.4 Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Detail
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Detail
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Detail
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Detail
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Detail
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR And CRISPR-Associated Genes Introduction
11.6.4 Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Detail
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Detail
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Detail
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Detail
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR And CRISPR-Associated Genes Introduction
11.10.4 Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Detail
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Detail
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Detail
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Detail
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Detail
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of GRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR And CRISPR-Associated Genes Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global CRISPR And CRISPR-Associated Genes Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global CRISPR And CRISPR-Associated Genes Market Share by Region (2018-2023)
Table 13. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global CRISPR And CRISPR-Associated Genes Market Share by Region (2024-2033)
Table 15. CRISPR And CRISPR-Associated Genes Market Trends
Table 16. CRISPR And CRISPR-Associated Genes Market Drivers
Table 17. CRISPR And CRISPR-Associated Genes Market Challenges
Table 18. CRISPR And CRISPR-Associated Genes Market Restraints
Table 19. Global CRISPR And CRISPR-Associated Genes Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global CRISPR And CRISPR-Associated Genes Market Share by Players (2018-2023)
Table 21. Global Top CRISPR And CRISPR-Associated Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR And CRISPR-Associated Genes as of 2022)
Table 22. Ranking of Global Top CRISPR And CRISPR-Associated Genes Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by CRISPR And CRISPR-Associated Genes Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR And CRISPR-Associated Genes Product Solution and Service
Table 26. Date of Enter into CRISPR And CRISPR-Associated Genes Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR And CRISPR-Associated Genes Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Type (2018-2023)
Table 30. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Type (2024-2033)
Table 32. Global CRISPR And CRISPR-Associated Genes Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Application (2018-2023)
Table 34. Global CRISPR And CRISPR-Associated Genes Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global CRISPR And CRISPR-Associated Genes Revenue Market Share by Application (2024-2033)
Table 36. North America CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 42. Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 43. Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size by Region (2024-2033) & (US$ Million)
Table 45. Latin America CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 48. Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size by Country (2024-2033) & (US$ Million)
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Product
Table 54. Thermo Fisher Scientific Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Editas Medicine Company Detail
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine CRISPR And CRISPR-Associated Genes Product
Table 59. Editas Medicine Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 60. Editas Medicine Recent Development
Table 61. Caribou Biosciences Company Detail
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences CRISPR And CRISPR-Associated Genes Product
Table 64. Caribou Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 65. Caribou Biosciences Recent Development
Table 66. CRISPR therapeutics Company Detail
Table 67. CRISPR therapeutics Business Overview
Table 68. CRISPR therapeutics CRISPR And CRISPR-Associated Genes Product
Table 69. CRISPR therapeutics Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 70. CRISPR therapeutics Recent Development
Table 71. Intellia therapeutics, Inc. Company Detail
Table 72. Intellia therapeutics, Inc. Business Overview
Table 73. Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Product
Table 74. Intellia therapeutics, Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 75. Intellia therapeutics, Inc. Recent Development
Table 76. Cellectis Company Detail
Table 77. Cellectis Business Overview
Table 78. Cellectis CRISPR And CRISPR-Associated Genes Product
Table 79. Cellectis Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 80. Cellectis Recent Development
Table 81. Horizon Discovery Plc Company Detail
Table 82. Horizon Discovery Plc Business Overview
Table 83. Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Product
Table 84. Horizon Discovery Plc Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 85. Horizon Discovery Plc Recent Development
Table 86. Sigma Aldrich Company Detail
Table 87. Sigma Aldrich Business Overview
Table 88. Sigma Aldrich CRISPR And CRISPR-Associated Genes Product
Table 89. Sigma Aldrich Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 90. Sigma Aldrich Recent Development
Table 91. Precision Biosciences Company Detail
Table 92. Precision Biosciences Business Overview
Table 93. Precision Biosciences CRISPR And CRISPR-Associated Genes Product
Table 94. Precision Biosciences Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 95. Precision Biosciences Recent Development
Table 96. Genscript Company Detail
Table 97. Genscript Business Overview
Table 98. Genscript CRISPR And CRISPR-Associated Genes Product
Table 99. Genscript Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 100. Genscript Recent Development
Table 101. Sangamo Biosciences Inc. Company Detail
Table 102. Sangamo Biosciences Inc. Business Overview
Table 103. Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Product
Table 104. Sangamo Biosciences Inc. Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 105. Sangamo Biosciences Inc. Recent Development
Table 106. Lonza Group Limited Company Detail
Table 107. Lonza Group Limited Business Overview
Table 108. Lonza Group Limited CRISPR And CRISPR-Associated Genes Product
Table 109. Lonza Group Limited Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 110. Lonza Group Limited Recent Development
Table 111. Integrated DNA Technologies Company Detail
Table 112. Integrated DNA Technologies Business Overview
Table 113. Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Product
Table 114. Integrated DNA Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 115. Integrated DNA Technologies Recent Development
Table 116. New England Biolabs Company Detail
Table 117. New England Biolabs Business Overview
Table 118. New England Biolabs CRISPR And CRISPR-Associated Genes Product
Table 119. New England Biolabs Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 120. New England Biolabs Recent Development
Table 121. Origene Technologies Company Detail
Table 122. Origene Technologies Business Overview
Table 123. Origene Technologies CRISPR And CRISPR-Associated Genes Product
Table 124. Origene Technologies Revenue in CRISPR And CRISPR-Associated Genes Business (2018-2023) & (US$ Million)
Table 125. Origene Technologies Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR And CRISPR-Associated Genes Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global CRISPR And CRISPR-Associated Genes Market Share by Type: 2022 VS 2033
Figure 3. Genome Editing Features
Figure 4. Genetic Engineering Features
Figure 5. GRNA Database/Gene Librar Features
Figure 6. CRISPR Plasmid Features
Figure 7. Human Stem Cells Features
Figure 8. Genetically Modified Organisms/Crops Features
Figure 9. Cell Line Engineering Features
Figure 10. Global CRISPR And CRISPR-Associated Genes Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 11. Global CRISPR And CRISPR-Associated Genes Market Share by Application: 2022 VS 2033
Figure 12. Biotechnology Companies Case Studies
Figure 13. Pharmaceutical Companies Case Studies
Figure 14. Academic Institutes Case Studies
Figure 15. Research and Development Institutes Case Studies
Figure 16. CRISPR And CRISPR-Associated Genes Report Years Considered
Figure 17. Global CRISPR And CRISPR-Associated Genes Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 18. Global CRISPR And CRISPR-Associated Genes Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 19. Global CRISPR And CRISPR-Associated Genes Market Share by Region: 2022 VS 2033
Figure 20. Global CRISPR And CRISPR-Associated Genes Market Share by Players in 2022
Figure 21. Global Top CRISPR And CRISPR-Associated Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR And CRISPR-Associated Genes as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by CRISPR And CRISPR-Associated Genes Revenue in 2022
Figure 23. North America CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. North America CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 25. United States CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 29. Germany CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific CRISPR And CRISPR-Associated Genes Market Share by Region (2018-2033)
Figure 37. China CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Japan CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. South Korea CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Southeast Asia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. India CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Australia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 45. Mexico CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Brazil CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa CRISPR And CRISPR-Associated Genes Market Share by Country (2018-2033)
Figure 49. Turkey CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Saudi Arabia CRISPR And CRISPR-Associated Genes Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 52. Editas Medicine Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 53. Caribou Biosciences Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 54. CRISPR therapeutics Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 55. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 56. Cellectis Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 57. Horizon Discovery Plc Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 58. Sigma Aldrich Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 59. Precision Biosciences Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 60. Genscript Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 61. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 62. Lonza Group Limited Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 63. Integrated DNA Technologies Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 64. New England Biolabs Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 65. Origene Technologies Revenue Growth Rate in CRISPR And CRISPR-Associated Genes Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries